2Askling J, Brandt L, Lapidus A, et al. Risk of haematopoi- etic cancer in patients with inflammatory bowel disease [ J] Gut, 2005,54(5 ) :617-622.
3Kandiel A, Fraser A G, Korelitz B I, et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine [ J ]. Gut, 2005,54 (8) :1121-1125.
4Homsak E, Micetic-Turk D, Bozic B. Autoantibodies pAN- CA, GAB and PAB in inflammatory bowel disease: preva- lence, characteristics and diagnostic value [ J ]. Wien Kiln Wochenschr, 2010,122( Suppl 2) : 19-25.
5Joosscns S, Colombel J F, Landers C, et al. Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis [ J ]. Gut, 2006,55 ( 11 ) : 1667-1669.
6Dotan I, Fishman S, Dgani Y, et al. Antibodies against lam- inaribioside and chitobioside are novel serologic markers in Crohn disease[ J]. Gastroenterology, 2006,131 (2) :366-378.
7Kim Y S, Kim Y H, Kim W H, et al. Diagnostic utility of anti-Saeeharomyees cerevisiae antibody (ASCA) and Inter- feron-gamma assay in the differential diagnosis of Crohn dis- ease and intestinal tuberculosis [ J ]. Clin Chim Aeta, 2011, 412(17-18) :1527-1532.
